Sleep alterations in an environmental neurotoxin-induced model of parkinsonism
- PMID: 20713046
- PMCID: PMC2955757
- DOI: 10.1016/j.expneurol.2010.08.005
Sleep alterations in an environmental neurotoxin-induced model of parkinsonism
Abstract
Parkinson's disease (PD) is classically defined as a motor disorder resulting from decreased dopamine production in the basal ganglia circuit. In an attempt to better diagnose and treat PD before the onset of severe motor dysfunction, recent attention has focused on the early, non-motor symptoms, which include but are not limited to sleep disorders such as excessive daytime sleepiness (EDS) and REM behavioral disorder (RBD). However, few animal models have been able to replicate both the motor and non-motor symptoms of PD. Here, we present a progressive rat model of parkinsonism that displays disturbances in sleep/wake patterns. Epidemiological studies elucidated a link between the Guamanian variant of Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex (ALS/PDC) and the consumption of flour made from the washed seeds of the plant Cycas micronesica (cycad). Our study examined the effects of prolonged cycad consumption on sleep/wake activity in male, Sprague-Dawley rats. Cycad-fed rats exhibited an increase in length and/or number of bouts of rapid eye movement (REM) sleep and Non-REM (NREM) sleep at the expense of wakefulness during the active period when compared to control rats. This hypersomnolent behavior suggests an inability to maintain arousal. In addition, cycad-fed rats had significantly fewer orexin cells in the hypothalamus. Our results reveal a novel rodent model of parkinsonism that includes an EDS-like syndrome that may be associated with a dysregulation of orexin neurons. Further characterization of this early, non-motor symptom, may provide potential therapeutic interventions in the treatment of PD.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures




Similar articles
-
Environmental neurotoxin-induced progressive model of parkinsonism in rats.Ann Neurol. 2010 Jul;68(1):70-80. doi: 10.1002/ana.22018. Ann Neurol. 2010. PMID: 20582986 Free PMC article.
-
A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep.BMC Neurosci. 2003 Sep 9;4:19. doi: 10.1186/1471-2202-4-19. BMC Neurosci. 2003. PMID: 12964948 Free PMC article.
-
Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation.Neurochem Int. 2011 Oct;59(5):686-94. doi: 10.1016/j.neuint.2011.06.015. Epub 2011 Jun 28. Neurochem Int. 2011. PMID: 21740944
-
[Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].Glas Srp Akad Nauka Med. 2011;(51):85-97. Glas Srp Akad Nauka Med. 2011. PMID: 22165729 Review. Serbian.
-
To eat or to sleep? Orexin in the regulation of feeding and wakefulness.Annu Rev Neurosci. 2001;24:429-58. doi: 10.1146/annurev.neuro.24.1.429. Annu Rev Neurosci. 2001. PMID: 11283317 Review.
Cited by
-
Polysomnographic Features of Sleep Disturbances and REM Sleep Behavior Disorder in the Unilateral 6-OHDA Lesioned Hemiparkinsonian Rat.Parkinsons Dis. 2014;2014:852965. doi: 10.1155/2014/852965. Epub 2014 Dec 25. Parkinsons Dis. 2014. PMID: 25610706 Free PMC article.
-
Rethinking cycad metabolite research.Commun Integr Biol. 2011 Jan;4(1):86-8. doi: 10.4161/cib.4.1.14084. Commun Integr Biol. 2011. PMID: 21509189 Free PMC article.
-
Animal models of Parkinson's disease: a gateway to therapeutics?Neurotherapeutics. 2014 Jan;11(1):92-110. doi: 10.1007/s13311-013-0234-1. Neurotherapeutics. 2014. PMID: 24158912 Free PMC article. Review.
-
Animal models of the non-motor features of Parkinson's disease.Neurobiol Dis. 2012 Jun;46(3):597-606. doi: 10.1016/j.nbd.2011.12.040. Epub 2012 Jan 3. Neurobiol Dis. 2012. PMID: 22236386 Free PMC article. Review.
-
Sleep Disorders in Rodent Models of Parkinson's Disease.Front Pharmacol. 2019 Nov 27;10:1414. doi: 10.3389/fphar.2019.01414. eCollection 2019. Front Pharmacol. 2019. PMID: 31827439 Free PMC article. Review.
References
-
- Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442–1446. - PubMed
-
- Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson’s disease and sleepiness: an integral part of PD. Neurology. 2002;58:1019–1024. - PubMed
-
- Barraud Q, Lambrecq V, Forni C, et al. Sleep disorders in Parkinson’s disease: the contribution of the MPTP non-human primate model. Exp Neurol. 2009;219 (2):574–582. - PubMed
-
- Baumann CR, Bassetti CL. Hypocretins (orexins) and sleep–wake disorders. Lancet Neurol. 2005;4:673–682. Review. - PubMed
-
- Carlsson A, Lindqvist M, Magnusson T. 3, 4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957;180:1200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous